119 related articles for article (PubMed ID: 12746941)
1. Montelukast does not protect against hyperoxia-induced inhibition of alveolarization in newborn rats.
Jouvencel P; Fayon M; Choukroun ML; Carles D; Montaudon D; Dumas E; Begueret H; Marthan R
Pediatr Pulmonol; 2003 Jun; 35(6):446-51. PubMed ID: 12746941
[TBL] [Abstract][Full Text] [Related]
2. Leukotrienes are indicated as mediators of hyperoxia-inhibited alveolarization in newborn rats.
Boros V; Burghardt JS; Morgan CJ; Olson DM
Am J Physiol; 1997 Mar; 272(3 Pt 1):L433-41. PubMed ID: 9124600
[TBL] [Abstract][Full Text] [Related]
3. Effects of phosphodiesterase 4 inhibition on alveolarization and hyperoxia toxicity in newborn rats.
Méhats C; Franco-Montoya ML; Boucherat O; Lopez E; Schmitz T; Zana E; Evain-Brion D; Bourbon J; Delacourt C; Jarreau PH
PLoS One; 2008; 3(10):e3445. PubMed ID: 18941502
[TBL] [Abstract][Full Text] [Related]
4. Clarithromycin, montelukast, and pentoxifylline combination treatment ameliorates experimental neonatal hyperoxic lung injury.
Demir K; Kumral A; Duman N; Sarioglu S; Yilmaz O; Yesilirmak DC; Kargi A; Ozkan H
J Matern Fetal Neonatal Med; 2008 Jun; 21(6):407-13. PubMed ID: 18570119
[TBL] [Abstract][Full Text] [Related]
5. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
[TBL] [Abstract][Full Text] [Related]
6. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist.
Tuğtepe H; Sener G; Cetinel S; Velioğlu-Oğünç A; Yeğen BC
Eur J Pharmacol; 2007 Feb; 557(1):69-75. PubMed ID: 17173892
[TBL] [Abstract][Full Text] [Related]
7. Postnatal growth of pulmonary acini and alveoli in normal and oxygen-exposed rats studied by serial section reconstructions.
Randell SH; Mercer RR; Young SL
Am J Anat; 1989 Sep; 186(1):55-68. PubMed ID: 2782288
[TBL] [Abstract][Full Text] [Related]
8. Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs.
Sener G; Kabasakal L; Cetinel S; Contuk G; Gedik N; Yeğen BC
Burns; 2005 Aug; 31(5):587-96. PubMed ID: 15935562
[TBL] [Abstract][Full Text] [Related]
9. Effects of retinoic acid on airspace development and lung collagen in hyperoxia-exposed newborn rats.
Veness-Meehan KA; Bottone FG; Stiles AD
Pediatr Res; 2000 Oct; 48(4):434-44. PubMed ID: 11004232
[TBL] [Abstract][Full Text] [Related]
10. [Effect of lethal hyperoxia on pulmonary development and lung injury in neonatal rats].
Zhu CP; Du J; Li QP; Feng ZC
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):945-8. PubMed ID: 16864083
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of leukotriene receptor antagonist montelukast on smoking-induced lung injury in Wistar rats.
Yüksel H; Ozbilgin K; Coskun S; Tuglu I
Acta Med Okayama; 2003 Feb; 57(1):13-9. PubMed ID: 12765219
[TBL] [Abstract][Full Text] [Related]
12. [Effect of losartan on lung fibrosis in neonatal rats with hyperoxia-induced chronic lung disease].
Chen N; Li JJ; Xue XD
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Dec; 9(6):591-4. PubMed ID: 18082049
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiological role of mast cells in collagen-induced arthritis: study with a cysteinyl leukotriene receptor antagonist, montelukast.
Shiota N; Shimoura K; Okunishi H
Eur J Pharmacol; 2006 Oct; 548(1-3):158-66. PubMed ID: 16949072
[TBL] [Abstract][Full Text] [Related]
14. Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast.
Sener G; Sakarcan A; Sehirli O; Ekşioğlu-Demiralp E; Sener E; Ercan F; Gedik N; Yeğen BC
Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):257-67. PubMed ID: 17499745
[TBL] [Abstract][Full Text] [Related]
15. [Protection of captopril against chronic lung disease induced by hyperoxia in neonatal rats].
Li JJ; Xue XD
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Apr; 9(2):169-73. PubMed ID: 17448318
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of montelukast which is cysteinyl-leukotriene receptor antagonist on gentamicin-induced nephrotoxicity and oxidative damage in rat kidney.
Otunctemur A; Ozbek E; Cekmen M; Cakir SS; Dursun M; Polat EC; Somay A; Ozbay N
Ren Fail; 2013; 35(3):403-10. PubMed ID: 23342977
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene D4 receptor antagonist montelukast alleviates water avoidance stress-induced degeneration of the gastrointestinal mucosa.
Ersoy Y; Cikler E; Cetinel S; Sener G; Ercan F
Prostaglandins Leukot Essent Fatty Acids; 2008 Mar; 78(3):189-97. PubMed ID: 18387287
[TBL] [Abstract][Full Text] [Related]
18. Role of N-methyl-D-aspartate receptor in hyperoxia-induced lung injury.
Tang F; Yue S; Luo Z; Feng D; Wang M; Qian C; Zhen X; Duan Y
Pediatr Pulmonol; 2005 Nov; 40(5):437-44. PubMed ID: 16163726
[TBL] [Abstract][Full Text] [Related]
19. [Protective effects of captopril on hyperoxia-induced lung injury in neonatal rats].
Li JJ; Yu ZL; Xue XD
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Feb; 8(1):41-4. PubMed ID: 16522239
[TBL] [Abstract][Full Text] [Related]
20. The leukotriene d4 receptor antagonist, montelukast, inhibits mast cell degranulation in the dermis induced by water avoidance stress.
Cikler E; Ersoy Y; Cetinel S; Ercan F
Acta Histochem; 2009; 111(2):112-8. PubMed ID: 18617226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
